Leap Therapeutics's activity chart (see below) currently has 30 price targets and 52 ratings on display.
Analysts' price targets on this stock were met 20% of the time, taking 117.7 days on average.
Most recent stock forecast was given by from HC WAINWRIGHT on 27-Mar-2025. First documented stock forecast 06-Mar-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Mar-2025
1 years 7 months 25 days ago
(27-Mar-2025)
0/6 (0%)
$2.92 (113.18%)
Buy Since 03-Jun-2021
$9
$11
2 years 8 months 2 days ago
(19-Mar-2024)
0/3 (0%)
$6.8 (309.09%)
Buy Since 17-May-2021
$15
2 years 8 months 3 days ago
(18-Mar-2024)
2/4 (50%)
$12.86 (600.93%)
77
Buy Since 04-Oct-2021
3 years 1 days ago
(19-Nov-2023)
0/3 (0%)
$30.9 (106.19%)
Buy Since 05-Apr-2022
3 years 7 days ago
(13-Nov-2023)
0/2 (0%)
$13.21 (348.55%)
What is LPTX (Leap Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on LPTX (Leap Therapeutics)?
Which analyst has the most public recommendations on LPTX (Leap Therapeutics)?
Which analyst is the currently most bullish on LPTX (Leap Therapeutics)?
Which analyst is the currently most reserved on LPTX (Leap Therapeutics)?